Disclosures for "Preliminary Evidence that Neflamapimod has a Beneficial Effect on Basal Forebrain Atrophy Assessed by MRI in Dementia with Lewy Bodies"
-
John Alam has received personal compensation for serving as an employee of CervoMed. John Alam has stock in CervoMed.
-
Dr. Koubiyr has nothing to disclose.
-
The institution of Dr. Schoonheim has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. The institution of Dr. Schoonheim has received research support from Dutch MS Research Foundation. The institution of Dr. Schoonheim has received research support from Eurostars-EUREKA. The institution of Dr. Schoonheim has received research support from Amsterdam Neuroscience. Dr. Schoonheim has received research support from ZonMW. The institution of Dr. Schoonheim has received research support from Atara Biotherapeutics. The institution of Dr. Schoonheim has received research support from Biogen. The institution of Dr. Schoonheim has received research support from BMS. The institution of Dr. Schoonheim has received research support from Merck. The institution of Dr. Schoonheim has received research support from Cervomed/EIP. The institution of Dr. Schoonheim has received research support from ECTRIMS.